Cheaper Migraine Drugs Outperform Newer, More Expensive Options: Oxford Study
By Cara Michelle Miller An Oxford study suggests that triptans are the most effective migraine treatment, outperforming newer, pricier options. For decades, inexpensive painkillers like aspirin and ibuprofen, along with triptans—drugs that narrow blood vessels in the brain to block migraine-triggering chemicals—have been prescribed for migraines. Recently, a new generation of migraine…
More Stories
Booking (NASDAQ:BKNG) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Booking (NASDAQ:BKNG – Free Report) from a hold rating to a buy rating in a research...
Expedia Group (NASDAQ:EXPE) Lowered to “Buy” Rating by StockNews.com
StockNews.com cut shares of Expedia Group (NASDAQ:EXPE – Free Report) from a strong-buy rating to a buy rating in a...
StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN)
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report published on Saturday morning. The brokerage...
United Microelectronics (NYSE:UMC) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of United Microelectronics (NYSE:UMC – Free Report) from a hold rating to a buy rating in a...
SenesTech (NASDAQ:SNES) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report released on Saturday. The firm issued...
QuickLogic (NASDAQ:QUIK) Posts Earnings Results, Misses Expectations By $0.01 EPS
QuickLogic (NASDAQ:QUIK – Get Free Report) issued its quarterly earnings data on Monday. The semiconductor company reported ($0.06) earnings per...